Acadia Pharmaceuticals (ACAD) Non-cash Items (2010 - 2025)

Acadia Pharmaceuticals' Non-cash Items history runs 15 years deep, the most recent figure standing at $79.3 million for Q4 2025.

• In Q4 2025, Non-cash Items rose 1032.92% year-over-year to $79.3 million; the TTM figure through Dec 2025 stood at $79.3 million (up 1032.92% YoY), while the FY2025 annual figure was $79.3 million, up 1032.92% from the prior year.
• Non-cash Items was $79.3 million for Q4 2025 at Acadia Pharmaceuticals, up from $7.0 million in the prior quarter.
• In the past five years, Non-cash Items ranged from a high of $91.0 million in Q4 2023 to a low of $1.1 million in Q4 2022.
• Historically, Non-cash Items has averaged $38.9 million across 5 years, with a median of $16.4 million in 2021.
• The sharpest annual moves came in 2022 and 2023: Non-cash Items plunged 93.59% in 2022, then jumped 8546.58% in 2023.
• A 5-year view of Non-cash Items shows it stood at $16.4 million in 2021, then slumped by 93.59% to $1.1 million in 2022, then surged by 8546.58% to $91.0 million in 2023, then plunged by 92.31% to $7.0 million in 2024, then soared by 1032.92% to $79.3 million in 2025.
• The last three Non-cash Items figures came in at $79.3 million (Q4 2025), $7.0 million (Q4 2024), and $91.0 million (Q4 2023), per Business Quant data.